Redd&Whyte Appoints HighRes Biosolutions as New US Distributor
News Feb 28, 2013
Redd&Whyte, an expert supplier of liquid handling automation for drug discovery and life science research applications, today announced it has appointed HighRes Biosolutions, a leading developer of flexible laboratory automation systems, as US distributor for its Preddator low-volume microplate dispensers. The appointment will provide US researchers with rapid access to, and support of, unique technology for achieving consistent results and reducing assay costs, by dispensing low-volumes of difficult reagents into microplates.
Under the terms of the agreement, HighRes Biosolutions will market Redd&Whyte’s Preddator range in North America. The versatile Preddator, which can dispense viscous liquids including gels, cell suspensions and DMSO in any microplate format from 96-3456 wells, will be integrated into HighRes’ patented MicroDock technology. This will allow scientists to easily add and remove the Preddator from HighRes’ automated assay preparation and screening systems.
Redd&Whyte chose HighRes to market its equipment in North America because the firm is respected for its modular design of versatile laboratory automation and specialist knowledge of integrating state-of-the-art liquid handlers into their systems. HighRes also has a large network of life science specialists across the USA, who will provide further information on integrated solutions that include the Preddator system.
Roger Poole, Managing Director of Redd&Whyte commented: "Recently, we have had great success in the North American market with our Preddator system and are delighted to have HighRes Biosolutions as our new distribution partner to support this growth.”
Poole added: “HighRes is a first-rate company, with an excellent reputation for its versatile approach to integrating only the best low-volume liquid handlers into their systems. Our unique, flexible low-volume microplate dispensing technology will perfectly complement the products HighRes provides so we’re excited to have them offering Preddator as part of their portfolio.”
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Synthetic Material to Support Stem Cells DevelopedNews
New substrates have been developed which can be used to raise stem cells for a wide variety of uses.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018
EMBL Course: RNA Sequencing Library Preparation - How Low Can You Go?
Mar 19 - Mar 23, 2018
EMBL Course: Analysis and Integration of Transcriptome and Proteome Data
Mar 12 - Mar 16, 2018